MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Regardless of impaired renal function, negative myoclonus can be induced by gabapetin and pregabalin

DY. Kwon, MH. Park (Gyenggi-Do, Republic of Korea)

Meeting: 2019 International Congress

Abstract Number: 1461

Keywords: Myoclonus: Clinical features, Myoclonus: Etiology and Pathogenesis

Session Information

Date: Tuesday, September 24, 2019

Session Title: Drug-Induced Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Agora 2 West, Level 2

Objective: This study evaluated pregabalin- or gabapentin-induced negative myoclonus according to renal function.

Background: Gabapentin and pregabalin are commonly used to control neuropathic pain and epilepsy. Myoclonus is a jerky, brief, and sudden interruption of voluntary muscle contraction, can be caused by anoxic brain injury, focal brain lesions, medications, metabolic etiology, and infection. Although gabapentin and pregabalin have been reported to induce positive myoclonus in some patients with impaired renal function, there are only a few studies describing pregabalin- or gabapentin-induced negative myoclonus.

Method: This study evaluated the patients with negative myoclonus who were referred to the department of neurology at a university-affiliated hospital and selected pregabalin- or gabapentin-induced negative myoclonus. Then reviewed the literature with respect to negative myoclonus.

Results: There were patients with negative myoclonus with or without renal dysfunction in this study. Among them, the neuropathic pain patients (27.3%) who were prescribed and developed negative myoclonus induced by pregabalin (11.7%) or gabapentin (15.6%). The patients with impaired renal function were 14.3%, while the patients with normal renal function were 85.7%. There have been previous case reports of pregabalin- and gabapentin-induced negative myoclonus.

Conclusion: Pregabalin- and gabapentin-induced negative myoclonus can develop even in patients with normal renal function. Physicians should keep in mind the possibility of patients developing negative myoclonus under treatment of pregabalin or gabapentin even in short period of time and with low dosage, and in the normal range of renal function.

References: Healy DG, et al. Pregabalin- and gabapentin-associated myoclonus in a patient with chronic renal failure. Mov Disord 2009; 24: 2028-9.

To cite this abstract in AMA style:

DY. Kwon, MH. Park. Regardless of impaired renal function, negative myoclonus can be induced by gabapetin and pregabalin [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/regardless-of-impaired-renal-function-negative-myoclonus-can-be-induced-by-gabapetin-and-pregabalin/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/regardless-of-impaired-renal-function-negative-myoclonus-can-be-induced-by-gabapetin-and-pregabalin/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley